Loopbaan van Timothy Sullivan
Eerdere bekende functies van Timothy Sullivan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01-01-2017 | 01-05-2020 |
| PFIZER, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 | 01-01-2017 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01-12-2012 | 01-06-2015 |
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 01-03-2010 | 01-12-2012 |
Opleiding van Timothy Sullivan
| University of Notre Dame | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Japan | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ARCUS BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Beurs
- Insiders
- Timothy Sullivan
- Ervaring
